The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
Abstract
Epidemiological and experimental observations support the hypothesis that chronic inflammation contributes to cancer development and progression; however, the mechanisms underlying the relationship between inflammation and cancer are poorly understood. To study these mechanisms, we have transfected the mouse 4T1 mammary carcinoma with the proinflammatory cytokine IL-1β to produce a chronic inflammatory microenvironment at the tumor site. Mice with 4T1/IL-1β tumors have a decreased survival time and elevated levels of immature splenic Gr1+CD11b+ myeloid-derived cells. These myeloid suppressor cells (MSC) are present in many patients with cancer and inhibit the activation of CD4+ and CD8+ T lymphocytes. 4T1/IL-1β-induced MSC do not express the IL-1R, suggesting that the cytokine does not directly activate MSC. Neither T or B cells nor NKT cells are involved in the IL-1β-induced increase of MSC because RAG2−/− mice and nude mice with 4T1/IL-1β tumors also have elevated MSC levels. MSC levels remain elevated in mice inoculated with 4T1/IL-1β even after the primary tumor is surgically removed, indicating that the IL-1β effect is long lived. Collectively, these findings suggest that inflammation promotes malignancy via proinflammatory cytokines, such as IL-1β, which enhance immune suppression through the induction of MSC, thereby counteracting immune surveillance and allowing the outgrowth and proliferation of malignant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Induction by Antigen of Intrathymic Apoptosis of CD4 + CD8 + TCR lo Thymocytes in Vivo
Murphy, K. M., Heimberger, A. B., & Loh, D. Y. (1990) · Science · doi:10.1126/science.2125367 · Cited by 1,735
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
IL-1 is required for tumor invasiveness and angiogenesis
Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., & Apte, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437939100 · Cited by 1,023
Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Inflammation and necrosis promote tumour growth
Vakkila, J., & Lotze, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1415 · Cited by 690
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Chronic Inflammation and Cancer
Oshima, M. (2013) · 肥満研究 · Cited by 580
Ernst, P. B., & Gold, B. D. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.615 · Cited by 554
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Sinha, P., Clements, V. K., & Ostrand-Rosenberg, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.636 · Cited by 466
Self-citationBlaser, M. J., Chyou, P.-H., & Nomura, A. M. Y. (1995) · PubMed · Cited by 399
Pulaski, B. A., & Ostrand‐Rosenberg, S. (1998) · PubMed · Cited by 394
Self-citationDanna, E. A., Sinha, P., Gilbert, M., Clements, V. K., Pulaski, B. A., & Ostrand-Rosenberg, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2646 · Cited by 371
Self-citationKusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Derangement of immune responses by myeloid suppressor cells
Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., & Bronte, V. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0443-2 · Cited by 335
Immature myeloid cells and cancer-associated immune suppression
Kusmartsev, S., & Gabrilovich, D. I. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297
CD8(+) T cell-mediated spontaneous diabetes in neonatal mice
Morgan, D. J., Liblau, R., Scott, B., Fleck, S., McDevitt, H. O., Sarvetnick, N., Lo, D., & Sherman, L. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.978 · Cited by 267
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3
Huang, Q., Yang, J., Lin, Y., Walker, C., Cheng, J., Liu, Z.-G., & Su, B. (2004) · Nature Immunology · doi:10.1038/ni1014 · Cited by 266
Miller, F. R., Miller, B. E., & Heppner, G. H. (1983) · PubMed · Cited by 262
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250
Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.469 · Cited by 249
Morgan, D. J., Kreuwel, H. T. C., Fleck, S., Levitsky, H. I., Pardoll, D. M., & Sherman, L. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.643 · Cited by 244
Interleukin-1—a major pleiotropic cytokine in tumor–host interactions
Apte, R. N., & Voronov, E. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00014-7 · Cited by 212
Differential Effects of IL-1α and IL-1β on Tumorigenicity Patterns and Invasiveness
Song, X., Voronov, E., Dvorkin, T., Fima, E., Cagnano, E., Benharroch, D., Shendler, Y., Bjorkdahl, O., Segal, S., Dinarello, C. A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6448 · Cited by 169
Vidal‐Vanaclocha, F., Amezaga, C. A. V.-D., Asumendi, A., Kaplanski, G., & Dinarello, C. A. (1994) · PubMed · Cited by 146
Ostrand‐Rosenberg, S., Grusby, M. J., & Clements, V. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6015 · Cited by 143
Self-citationMuroi, M., Ohnishi, T., & Tanamoto, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205966200 · Cited by 108
Interleukin 1-Dependent and -Independent Mouse Melanoma Metastases
Anasagasti, M. J., Olaso, E., Calvo, F., Mendoza, L., Martin, J. J., Bidaurrazaga, J., & Vidal‐Vanaclocha, F. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.9.645 · Cited by 58
Dissanayake, S. K., Thompson, J. A., Bosch, J. J., Clements, V. K., Chen, P. W., Ksander, B. R., & Ostrand‐Rosenberg, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2634 · Cited by 53
Self-citationWingren, A. G., Björkdahl, O., Labuda, T., Björk, L., Andersson, U., Gullberg, U., Hedlund, G., Sjögren, H. O., Kalland, T., Widegren, B., et al. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0113 · Cited by 39
Björkdahl, O., Wingren, A. G., Hedlund, G., et al. (1997) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050383 · Cited by 22
Björkdahl, O., Dohlsten, M., & Sjögren, H. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700248 · Cited by 20
Cited by
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Self-citationModes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Metadata
- Authors
- Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., & Ostrand-Rosenberg, S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-01
- Volume
- 176
- Issue
- 1
- Pages
- 284-290
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1494453913
- Cited by
- 539
- References
- 39
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.